会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Mutant having uracil phosphoribosyl transferase activity
    • 具有尿嘧啶磷酸核糖基转移酶活性的突变体
    • US06596533B1
    • 2003-07-22
    • US09446084
    • 2000-08-14
    • Philippe ErbsRichard Jund
    • Philippe ErbsRichard Jund
    • C12N1585
    • C12N9/1077A61K38/00A61K48/00C07K2319/00C12N2799/022
    • The focus of the present invention is a polypeptide having a uracil phosphoribosyl transferase (UPRTase) activity achieved by mutation of one or more residues of the UPRTase. The invention also relates to a nucleotide sequence coding for the UPRTase mutant, a vector for expressing the nucleotide sequence, a viral particle, and a host cell, as well as a composition containing these. The invention further relates to the therapeutic use and method of treatment by using the mutant UPRTases and related compositions. The invention is particularly useful in the context of therapy by suicide genes, notably for treating proliferative and infectious diseases.
    • 本发明的重点是具有通过UPRT酶的一个或多个残基的突变而实现的尿嘧啶磷酸核糖转移酶(UPRTase)活性的多肽。 本发明还涉及编码UPRTase突变体的核苷酸序列,用于表达核苷酸序列的载体,病毒颗粒和宿主细胞,以及含有它们的组合物。 本发明还涉及通过使用突变型UPRT酶和相关组合物的治疗用途和治疗方法。 本发明在自杀基因治疗的上下文中特别有用,特别是用于治疗增殖性和感染性疾病。